Inventors:
Arvid Carlsson - Gothenburg, SE
Carol A. Tamminga - Dallas TX, US
Maria L. Carlsson - Gothenburg, SE
Johan Rung - Askim, SE
Marie Nilsson - Hisings Backa, SE
Adrienne C. Lahti - Birmingham AL, US
International Classification:
A61K 31/4418, A61P 25/10, A61P 1/08, A61P 25/16, A61P 25/18, A61P 25/14, A61P 25/30, A61P 25/22
Abstract:
At least one embodiment of the present invention relates to the use of a dopamine stabilizing substance in an oral, subcutaneous or intramuscular daily dose of 1-20 mg or in an intravenous daily dose of 0.1-2 mg in treatment of a neurological or psychiatric disorder characterized by a hypofunction of the dopamine system. At least one embodiment of the invention also relates to the use of a dopamine stabilizing substance in an oral, subcutaneous or intramuscular daily dose of 25-50 mg in treatment of a disorder caused by instability of neural circuits.